Literature DB >> 17021082

Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus.

Yangjian Cheng1, Jianjun Niu, Yongyou Zhang, Jianwei Huang, Qingge Li.   

Abstract

Armored RNA has been increasingly used as both an external and internal positive control in nucleic acid-based assays for RNA virus. In order to facilitate armored RNA purification, a His6 tag was introduced into the loop region of the MS2 coat protein, which allows the exposure of multiple His tags on the surface during armored RNA assembly. The His-tagged armored RNA particles were purified to homogeneity and verified to be free of DNA contamination in a single run of affinity chromatography. A fragment of severe acute respiratory syndrome coronavirus (SARS-CoV) genome targeted for SARS-CoV detection was chosen for an external positive control preparation. A plant-specific gene sequence was chosen for a universal noncompetitive internal positive control preparation. Both controls were purified by Co2+ affinity chromatography and were included in a real-time reverse transcription-PCR assay for SARS-CoV. The noncompetitive internal positive control can be added to clinical samples before RNA extraction and enables the identification of potential inhibitive effects without interfering with target amplification. The external control could be used for the quantification of viral loads in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021082      PMCID: PMC1594775          DOI: 10.1128/JCM.00713-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Synthetic viral particles promise to be valuable in the standardization of molecular diagnostic assays for hepatitis C virus.

Authors:  C P Cartwright
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

2.  Quality control PCR: a method for detecting inhibitors of Taq DNA polymerase.

Authors:  R A Reiss; B Rutz
Journal:  Biotechniques       Date:  1999-11       Impact factor: 1.993

3.  Use of fusions to viral coat proteins as antigenic carriers for vaccine development.

Authors:  P G Stockley; R A Mastico
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 4.  Current recommendations for positive controls in RT-PCR assays.

Authors:  T Lion
Journal:  Leukemia       Date:  2001-07       Impact factor: 11.528

5.  Ribonuclease-resistant RNA controls and standards.

Authors:  D Brown; B L Pasloske
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

6.  Internal control for quality assurance of diagnostic RT-PCR.

Authors:  M Willhauck; S Vogel; U Keilholz
Journal:  Biotechniques       Date:  1998-10       Impact factor: 1.993

7.  Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids.

Authors:  K G Heal; H R Hill; P G Stockley; M R Hollingdale; A W Taylor-Robinson
Journal:  Vaccine       Date:  1999-09       Impact factor: 3.641

8.  Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus.

Authors:  C R WalkerPeach; M Winkler; D B DuBois; B L Pasloske
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

9.  Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.

Authors:  Eric Q Konnick; Sheri M Williams; Edward R Ashwood; David R Hillyard
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

10.  Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus.

Authors:  Adam M Bressler; Frederick S Nolte
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more
  12 in total

Review 1.  Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications.

Authors:  Keith J M Moore; Jeremy Cahill; Guy Aidelberg; Rachel Aronoff; Ali Bektaş; Daniela Bezdan; Daniel J Butler; Sridar V Chittur; Martin Codyre; Fernan Federici; Nathan A Tanner; Scott W Tighe; Randy True; Sarah B Ware; Anne L Wyllie; Evan E Afshin; Andres Bendesky; Connie B Chang; Richard Dela Rosa; Eran Elhaik; David Erickson; Andrew S Goldsborough; George Grills; Kathrin Hadasch; Andrew Hayden; Seong-Young Her; Julie A Karl; Chang Hee Kim; Alison J Kriegel; Thomas Kunstman; Zeph Landau; Kevin Land; Bradley W Langhorst; Ariel B Lindner; Benjamin E Mayer; Lee A McLaughlin; Matthew T McLaughlin; Jenny Molloy; Christopher Mozsary; Jerry L Nadler; Melinee D'Silva; David Ng; David H O'Connor; Jerry E Ongerth; Olayinka Osuolale; Ana Pinharanda; Dennis Plenker; Ravi Ranjan; Michael Rosbash; Assaf Rotem; Jacob Segarra; Stephan Schürer; Scott Sherrill-Mix; Helena Solo-Gabriele; Shaina To; Merly C Vogt; Albert D Yu; Christopher E Mason
Journal:  J Biomol Tech       Date:  2021-09

2.  Preparation of armored RNA as a control for multiplex real-time reverse transcription-PCR detection of influenza virus and severe acute respiratory syndrome coronavirus.

Authors:  Xin-Fen Yu; Jing-Cao Pan; Rong Ye; Hai-Qing Xiang; Yu Kou; Zhi-Cheng Huang
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

3.  Co-expression of RNA-protein complexes in Escherichia coli and applications to RNA biology.

Authors:  Luc Ponchon; Marjorie Catala; Bili Seijo; Marguerite El Khouri; Frédéric Dardel; Sylvie Nonin-Lecomte; Carine Tisné
Journal:  Nucleic Acids Res       Date:  2013-06-26       Impact factor: 16.971

4.  Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition.

Authors:  Lester M Shulman; Musa Hindiyeh; Khitam Muhsen; Dani Cohen; Ella Mendelson; Danit Sofer
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

5.  Preparation of MS2 Phage-Like Particles and Their Use As Potential Process Control Viruses for Detection and Quantification of Enteric RNA Viruses in Different Matrices.

Authors:  Pavel Mikel; Petra Vasickova; Radek Tesarik; Hana Malenovska; Pavel Kulich; Tomas Vesely; Petr Kralik
Journal:  Front Microbiol       Date:  2016-12-01       Impact factor: 5.640

6.  Internal control for real-time polymerase chain reaction based on MS2 bacteriophage for RNA viruses diagnostics.

Authors:  Miriam Ribas Zambenedetti; Daniela Parada Pavoni; Andreia Cristine Dallabona; Alejandro Correa Dominguez; Celina de Oliveira Poersch; Stenio Perdigão Fragoso; Marco Aurélio Krieger
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-04-06       Impact factor: 2.743

7.  One-plasmid double-expression His-tag system for rapid production and easy purification of MS2 phage-like particles.

Authors:  Pavel Mikel; Petra Vasickova; Petr Kralik
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

8.  Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study.

Authors:  Min Zhang; Guangdi Li; Jia Shang; Chen Pan; Minxiang Zhang; Zhibiao Yin; Qing Xie; Yanzhong Peng; Qing Mao; Xinqiang Xiao; Yongfang Jiang; Kaizhong Luo; Yun Xu; Hai Ding; Wenzhou Fan; Vidaurre Diego; Mahmoud Reza Pourkarim; Erik De Clercq; Guiqiang Wang; Guozhong Gong
Journal:  Hepatol Int       Date:  2020-02-25       Impact factor: 6.047

9.  Development and Evaluation of a One-Step Quantitative RT-PCR Assay for Detection of Lassa Virus.

Authors:  Vladimir G Dedkov; N 'Faly Magassouba; Marina V Safonova; Ekaterina V Naydenova; Andrey A Ayginin; Barre Soropogui; Fode Kourouma; Amara B Camara; Jacob Camara; Andrey A Kritzkiy; Igor V Tuchkov; Mikhail Yu Shchelkanov; Victor V Maleev
Journal:  J Virol Methods       Date:  2019-06-03       Impact factor: 2.014

10.  Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology

Authors:  Mohammad Gholami; Mehrdad Ravanshad; Kazem Baesi; Siamak M. Samiee; Negin Hosseini Rozbahani; Minoo Mohraz
Journal:  Iran Biomed J       Date:  2018-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.